SEARCH

SEARCH BY CITATION

References

  • Abeles, A.M. & Pillinger, M.H. (2006) Statins as antiinflammatory and immunomodulatory agents: a future in rheumatologic therapy? Arthritis and Rheumatism, 54, 393407.
  • Abraham, C. & Cho, J.H. (2006) Functional consequences of NOD2 (CARD15) mutations. Inflammatory Bowel Diseases, 12, 641650.
  • Aderka, D. (1996) The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine & Growth Factor Reviews, 7, 231240.
  • Aganna, E., Hammond, L., Hawkins, P.N., Aldea, A., McKee, S.A., Van Amstel, H.K., Mischung, C., Kusuhara, K., Saulsbury, F.T., Lachmann, H.J., Bybee, A., McDermott, E.M., La, R.M., Arostegui, J.I., Campistol, J.M., Worthington, S., High, K.P., Molloy, M.G., Baker, N., Bidwell, J.L., Castaner, J.L., Whiteford, M.L., Janssens-Korpola, P.L., Manna, R., Powell, R.J., Woo, P., Solis, P., Minden, K., Frenkel, J., Yague, J., Mirakian, R.M., Hitman, G.A. & McDermott, M.F. (2003) Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis and Rheumatism, 48, 26322644.
  • Agostini, L., Martinon, F., Burns, K., McDermott, M.F., Hawkins, P.N. & Tschopp, J. (2004) NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity, 20, 319325.
  • Aksentijevich, I., Galon, J., Soares, M., Mansfield, E., Hull, K., Oh, H.H., Goldbach-Mansky, R., Dean, J., Athreya, B., Reginato, A.J., Henrickson, M., Pons-Estel, B., O’Shea, J.J. & Kastner, D.L. (2001) The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. American Journal of Human Genetics, 69, 301314.
  • Aksentijevich, I., Nowak, M., Mallah, M., Chae, J.J., Watford, W.T., Hofmann, S.R., Stein, L., Russo, R., Goldsmith, D., Dent, P., Rosenberg, H.F., Austin, F., Remmers, E.F., Balow, Jr, J.E., Rosenzweig, S., Komarow, H., Shoham, N.G., Wood, G., Jones, J., Mangra, N., Carrero, H., Adams, B.S., Moore, T.L., Schikler, K., Hoffman, H., Lovell, D.J., Lipnick, R., Barron, K., O’Shea, J.J., Kastner, D.L. & Goldbach-Mansky, R. (2002) De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis and Rheumatism, 46, 33403348.
  • Aksentijevich, I., Putnam, D., Remmers, E.F., Mueller, J.L., Le, J., Kolodner, R.D., Moak, Z., Chuang, M., Austin, F., Goldbach-Mansky, R., Hoffman, H.M. & Kastner, D.L. (2007) The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis and Rheumatism, 56, 12731285.
  • Aldea, A., Campistol, J.M., Arostegui, J.I., Rius, J., Maso, M., Vives, J. & Yague, J. (2004) A severe autosomal-dominant periodic inflammatory disorder with renal AA amyloidosis and colchicine resistance associated to the MEFV H478Y variant in a Spanish kindred: an unusual familial Mediterranean fever phenotype or another MEFV-associated periodic inflammatory disorder? American Journal of Medical Genetics Part A, 124, 6773.
  • Alexander, T., Klotz, O., Feist, E., Ruther, K., Burmester, G.R. & Pleyer, U. (2005) Successful treatment of acute visual loss in Muckle-Wells syndrome with interleukin 1 receptor antagonist. Annals of the Rheumatic Diseases, 64, 12451246.
  • Al-Mosawi, Z.S., Al-Saad, K.K., Ijadi-Maghsoodi, R., El-Shanti, H.I. & Ferguson, P.J. (2007) A splice site mutation confirms the role of LPIN2 in Majeed syndrome. Arthritis and Rheumatism, 56, 960964.
  • Appels, C.W. & Kloppenburg, M. (2006) [Muckle-Wells syndrome: a rare periodic fever syndrome]. Nederlands Tijdschrift voor Geneeskunde, 150, 16281631.
  • Arkwright, P.D., McDermott, M.F., Houten, S.M., Frenkel, J., Waterham, H.R., Aganna, E., Hammond, L.J., Mirakian, R.M., Tomlin, P.I., Vijaydurai, P.I. & Cant, A.J. (2002) Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept. Clinical and Experimental Immunology, 130, 484488.
  • Arostegui, J.I., Aldea, A., Modesto, C., Rua, M.J., Arguelles, F., Gonzalez-Ensenat, M.A., Ramos, E., Rius, J., Plaza, S., Vives, J. & Yague, J. (2004) Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene. Arthritis and Rheumatism, 50, 40454050.
  • Arostegui, J.I., Solis, P., Aldea, A., Cantero, T., Rius, J., Bahillo, P., Plaza, S., Vives, J., Gomez, S. & Yague, J. (2005) Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response. European Journal of Pediatrics, 164, 1316.
  • Badour, K., Zhang, J., Shi, F., McGavin, M.K., Rampersad, V., Hardy, L.A., Field, D. & Siminovitch, K.A. (2003a) The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse. Immunity, 18, 141154.
  • Badour, K., Zhang, J. & Siminovitch, K.A. (2003b) The Wiskott-Aldrich syndrome protein: forging the link between actin and cell activation. Immunological Reviews, 192, 98112.
  • Badour, K., Zhang, J., Shi, F., Leng, Y., Collins, M. & Siminovitch, K.A. (2004) Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation. Journal of Experimental Medicine, 199, 99112.
  • Banner, D.W., D’Arcy, A., Janes, W., Gentz, R., Schoenfeld, H.J., Broger, C., Loetscher, H. & Lesslauer, W. (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell, 73, 431445.
  • Baum, W., Kirkin, V., Fernandez, S.B., Pick, R., Lettau, M., Janssen, O. & Zornig, M. (2005) Binding of the intracellular Fas ligand (FasL) domain to the adaptor protein PSTPIP results in a cytoplasmic localization of FasL. Journal of Biological Chemistry, 280, 4001240024.
  • Becker, M.L. & Rose, C.D. (2005) Blau syndrome and related genetic disorders causing childhood arthritis. Current Rheumatology Reports, 7, 427433.
  • Becker, M.L., Martin, T.M., Doyle, T.M. & Rose, C.D. (2007) Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15. Arthritis and Rheumatism, 56, 12921294.
  • Belkhir, R., Moulonguet-Doleris, L., Hachulla, E., Prinseau, J., Baglin, A. & Hanslik, T. (2007) Treatment of familial Mediterranean fever with anakinra. Annals of Internal Medicine, 146, 825826.
  • Bleeker-Rovers, C. & Van Der Meer, J.W. (2005) Fever of unknown origin. Medicine (Baltimore), 33, 3336.
  • Bodar, E.J., Van Der Hilst, J.C., Drenth, J.P., Van Der Meer, J.W. & Simon, A. (2005) Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Netherlands Journal of Medicine, 63, 260264.
  • Bodar, E.J., Van Der Hilst, J.C., Van, H.W., Van Der Meer, J.W., Drenth, J.P. & Simon, A. (2007) Defective apoptosis of peripheral blood lymphocytes in hyper-IgD and periodic fever syndrome. Blood, 109, 24162418.
  • Boschan, C., Witt, O., Lohse, P., Foeldvari, I., Zappel, H. & Schweigerer, L. (2006) Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment. American Journal of Medical Genetics Part A, 140, 883886.
  • Cailliez, M., Garaix, F., Rousset-Rouviere, C., Bruno, D., Kone-Paut, I., Sarles, J., Chabrol, B. & Tsimaratos, M. (2006) Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis. Journal of Inherited Metabolic Disease, 29, 763.
  • Calguneri, M., Apras, S., Ozbalkan, Z. & Ozturk, M.A. (2004a) The efficacy of interferon-alpha in a patient with resistant familial Mediterranean fever complicated by polyarteritis nodosa. Internal Medicine, 43, 612614.
  • Calguneri, M., Apras, S., Ozbalkan, Z., Ozturk, M.A., Ertenli, I. & Kiraz, S. (2004b) The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients. Clinical and Experimental Rheumatology, 22, S41S44.
  • Callejas, J.L., Oliver, J., Martin, J. & Ortego, N. (2007) Anakinra in mutation-negative CINCA syndrome. Clinical Rheumatology, 26, 576577.
  • Caroli, F., Pontillo, A., D’Osualdo, A., Travan, L., Ceccherini, I., Crovella, S., Alessio, M., Stabile, A., Gattorno, M., Tommasini, A., Martini, A. & Lepore, L. (2007) Clinical and genetic characterization of Italian patients affected by CINCA syndrome. Rheumatology (Oxford), 46, 473478.
  • Centola, M., Wood, G., Frucht, D.M., Galon, J., Aringer, M., Farrell, C., Kingma, D.W., Horwitz, M.E., Mansfield, E., Holland, S.M., O’Shea, J.J., Rosenberg, H.F., Malech, H.L. & Kastner, D.L. (2000) The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood, 95, 32233231.
  • Chae, J.J., Komarow, H.D., Cheng, J., Wood, G., Raben, N., Liu, P.P. & Kastner, D.L. (2003) Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Molecular Cell, 11, 591604.
  • Chae, J.J., Wood, G., Masters, S.L., Richard, K., Park, G., Smith, B.J. & Kastner, D.L. (2006) The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proceedings of the National Academy of Sciences of the United States of America, 103, 99829987.
  • Chamaillard, M., Girardin, S.E., Viala, J. & Philpott, D.J. (2003) Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cellullar Microbiology, 5, 581592.
  • Chan, F.K., Chun, H.J., Zheng, L., Siegel, R.M., Bui, K.L. & Lenardo, M.J. (2000) A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science, 288, 23512354.
  • Cortis, E., De, B.F., Insalaco, A., Cioschi, S., Muratori, F., D’Urbano, L.E. & Ugazio, A.G. (2004) Abnormal production of tumor necrosis factor (TNF) -- alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome [corrected]. Journal of Pediatrics, 145, 851855.
  • Cote, J.F., Chung, P.L., Theberge, J.F., Halle, M., Spencer, S., Lasky, L.A. & Tremblay, M.L. (2002) PSTPIP is a substrate of PTP-PEST and serves as a scaffold guiding PTP-PEST toward a specific dephosphorylation of WASP. Journal of Biological Chemistry, 277, 29732986.
  • Coward, W.R., Marei, A., Yang, A., Vasa-Nicotera, M.M. & Chow, S.C. (2006) Statin-induced proinflammatory response in mitogen-activated peripheral blood mononuclear cells through the activation of caspase-1 and IL-18 secretion in monocytes. Journal of Immunology, 176, 52845292.
  • Cuisset, L., Drenth, J.P., Simon, A., Vincent, M.F., Van Der Velde Viser, S., Van Der Meer, J.W., Grateau, G. & Delpech, M. (2001) Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. European Journal of Human Genetics, 9, 260266.
  • D’Osualdo, A., Ferlito, F., Prigione, I., Obici, L., Meini, A., Zulian, F., Pontillo, A., Corona, F., Barcellona, R., Di, D.M., Santamaria, G., Traverso, F., Picco, P., Baldi, M., Plebani, A., Ravazzolo, R., Ceccherini, I., Martini, A. & Gattorno, M. (2006) Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications. Arthritis and Rheumatism, 54, 9981008.
  • Dalgic, B., Egritas, O., Sari, S. & Cuisset, L. (2007) A variant Muckle-Wells syndrome with a novel mutation in CIAS1 gene responding to anakinra. Pediatric Nephrology, 22, 13911394.
  • Daysal, S., Akcil, G., Goker, B., Haznedaroglu, S., Ercan, N. & Ozturk, M.A. (2005) Infliximab therapy in a patient with familial Mediterranean fever and chronic hip arthritis. Arthritis and Rheumatism, 53, 146147.
  • Deltas, C.C., Mean, R., Rossou, E., Costi, C., Koupepidou, P., Hadjiyanni, I., Hadjiroussos, V., Petrou, P., Pierides, A., Lamnisou, K. & Koptides, M. (2002) Familial Mediterranean fever (FMF) mutations occur frequently in the Greek-Cypriot population of Cyprus. Genetic Testing, 6, 1521.
  • Demirkaya, E., Caglar, M.K., Waterham, H.R., Topaloglu, R. & Ozen, S. (2006) A patient with hyper-IgD syndrome responding to anti-TNF treatment. Clinical Rheumatology, 26, 17571759.
  • Diaz, A., Hu, C., Kastner, D.L., Schaner, P., Reginato, A.M., Richards, N. & Gumucio, D.L. (2004) Lipopolysaccharide-induced expression of multiple alternatively spliced MEFV transcripts in human synovial fibroblasts: a prominent splice isoform lacks the C-terminal domain that is highly mutated in familial Mediterranean fever. Arthritis and Rheumatism, 50, 36793689.
  • Dierselhuis, M.P., Frenkel, J., Wulffraat, N.M. & Boelens, J.J. (2005) Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology (Oxford), 44, 406408.
  • Dode, C., Andre, M., Bienvenu, T., Hausfater, P., Pecheux, C., Bienvenu, J., Lecron, J.C., Reinert, P., Cattan, D., Piette, J.C., Szajnert, M.F., Delpech, M. & Grateau, G. (2002) The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis and Rheumatism, 46, 21812188.
  • Dollfus, H., Hafner, R., Hofmann, H.M., Russo, R.A., Denda, L., Gonzales, L.D., DeCunto, C., Premoli, J., Melo-Gomez, J., Jorge, J.P., Vesely, R., Stubna, M., Dufier, J.L. & Prieur, A.M. (2000) Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood. Archives of Ophthalmology, 118, 13861392.
  • Dowds, T.A., Masumoto, J., Chen, F.F., Ogura, Y., Inohara, N. & Nunez, G. (2003) Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochemical and Biophysical Research Communications, 302, 575580.
  • Dowds, T.A., Masumoto, J., Zhu, L., Inohara, N. & Nunez, G. (2004) Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. Journal of Biological Chemistry, 279, 2192421928.
  • Drenth, J.P., Boom, B.W., Toonstra, J. & Van Der Meer, J.W. (1994) Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper IgD Study Group. Archives of Dermatology, 130, 5965.
  • Drenth, J.P., Van Deuren, M., Van Der Ven-Jongekrijg, J., Schalkwijk, C.G. & Van Der Meer, J.W. (1995) Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood, 85, 35863593.
  • Drenth, J.P., Van Der Meer, J.W. & Kushner, I. (1996) Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells. Journal of Immunology, 157, 400404.
  • Drenth, J.P., Cuisset, L., Grateau, G., Vasseur, C., Van De Velde-Visser, S.D., De Jong, J.G., Beckmann, J.S., Van Der Meer, J.W. & Delpech, M. (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nature Genetics, 22, 178181.
  • Drenth, J.P., Vonk, A.G., Simon, A., Powell, R. & Van Der Meer, J.W. (2001) Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial. Journal of Pharmacology and Experimental Therapeutics, 298, 12211226.
  • Drewe, E., McDermott, E.M. & Powell, R.J. (2000) Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome. New England Journal of Medicine, 343, 10441045.
  • Drewe, E., McDermott, E.M., Powell, P.T., Isaacs, J.D. & Powell, R.J. (2003) Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology (Oxford), 42, 235239.
  • Drewe, E., Huggins, M.L., Morgan, A.G., Cassidy, M.J. & Powell, R.J. (2004) Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology (Oxford), 43, 14051408.
  • Dumontet, C. & Sikic, B.I. (1999) Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. Journal of Clinical Oncology, 17, 10611070.
  • Dybowski, F., Jakobs, B., Altmeyer, P. & Braun, J. (2006) [Successful treatment of clinical manifestations of Muckle-Wells syndrome with anakinra]. Deutsche Medizinische Wochenschrift, 131, 18631866.
  • Federici, L., Rittore-Domingo, C., Kone-Paut, I., Jorgensen, C., Rodiere, M., LE, Q.A. & Touitou, I. (2006) A decision tree for genetic diagnosis of hereditary periodic fevers in unselected patients. Annals of the Rheumatic Diseases, 65, 14271432.
  • Federico, G., Rigante, D., Pugliese, A.L., Ranno, O., Catania, S. & Stabile, A. (2003) Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome. Scandinavian Journal of Rheumatology, 32, 312314.
  • Feldmann, J., Prieur, A.M., Quartier, P., Berquin, P., Certain, S., Cortis, E., Teillac-Hamel, D., Fischer, A. & De Saint, B.G. (2002) Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. American Journal of Human Genetics, 71, 198203.
  • Ferguson, P.J., Bing, X., Vasef, M.A., Ochoa, L.A., Mahgoub, A., Waldschmidt, T.J., Tygrett, L.T., Schlueter, A.J. & El-Shanti, H. (2006) A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone, 38, 4147.
  • Fielding, C.A., Siebert, S., Rowe, M. & Brennan, P. (2004) Analysis of human tumour necrosis factor receptor 1 dominant-negative mutants reveals a major region controlling cell surface expression. FEBS Letters, 570, 138142.
  • Frenkel, J., Rijkers, G.T., Mandey, S.H., Buurman, S.W., Houten, S.M., Wanders, R.J., Waterham, H.R. & Kuis, W. (2002) Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis and Rheumatism, 46, 27942803.
  • Frenkel, J., Wulffraat, N.M. & Kuis, W. (2004) Anakinra in mutation-negative NOMID/CINCA syndrome: comment on the articles by Hawkins et al and Hoffman and Patel. Arthritis and Rheumatism, 50, 37383739.
  • Fujisawa, A., Kambe, N., Saito, M., Nishikomori, R., Tanizaki, H., Kanazawa, N., Adachi, S., Heike, T., Sagara, J., Suda, T., Nakahata, T. & Miyachi, Y. (2007) Disease-associated mutations in CIAS1 induce cathepsin B-dependent rapid cell death of human THP-1 monocytic cells. Blood, 109, 29032911.
  • Gaeta, M.L., Johnson, D.R., Kluger, M.S. & Pober, J.S. (2000) The death domain of tumor necrosis factor receptor 1 is necessary but not sufficient for Golgi retention of the receptor and mediates receptor desensitization. Laboratory Investigation, 80, 11851194.
  • Galon, J., Aksentijevich, I., McDermott, M.F., O’Shea, J.J. & Kastner, D.L. (2000) TNFRSF1A mutations and autoinflammatory syndromes. Current Opinion in Immunology, 12, 479486.
  • Gdynia, H.J., Sperfeld, A.D. & Haerter, G. (2006) Histologic signs of inflammatory myopathy in familial Mediterranean fever. Journal of Clinical Rheumatology, 12, 265266.
  • Girardin, S.E., Boneca, I.G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D.J. & Sansonetti, P.J. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. Journal of Biological Chemistry, 278, 88698872.
  • Goldbach-Mansky, R., Dailey, N.J., Canna, S.W., Gelabert, A., Jones, J., Rubin, B.I., Kim, H.J., Brewer, C., Zalewski, C., Wiggs, E., Hill, S., Turner, M.L., Karp, B.I., Aksentijevich, I., Pucino, F., Penzak, S.R., Haverkamp, M.H., Stein, L., Adams, B.S., Moore, T.L., Fuhlbrigge, R.C., Shaham, B., Jarvis, J.N., O’Neil, K., Vehe, R.K., Beitz, L.O., Gardner, G., Hannan, W.P., Warren, R.W., Horn, W., Cole, J.L., Paul, S.M., Hawkins, P.N., Pham, T.H., Snyder, C., Wesley, R.A., Hoffmann, S.C., Holland, S.M., Butman, J.A. & Kastner, D.L. (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. New England Journal of Medicine, 355, 581592.
  • Granel, B., Serratrice, J., Disdier, P. & Weiller, P.J. (2005) Dramatic improvement with anakinra in a case of chronic infantile neurological cutaneous and articular (CINCA) syndrome. Rheumatology (Oxford), 44, 689690.
  • Gutierrez, O., Pipaon, C., Inohara, N., Fontalba, A., Ogura, Y., Prosper, F., Nunez, G. & Fernandez-Luna, J.L. (2002) Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. Journal of Biological Chemistry, 277, 4170141705.
  • Hawkins, P.N., Lachmann, H.J. & McDermott, M.F. (2003) Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. New England Journal of Medicine, 348, 25832584.
  • Hawkins, P.N., Lachmann, H.J., Aganna, E. & McDermott, M.F. (2004a) Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis and Rheumatism, 50, 607612.
  • Hawkins, P.N., Bybee, A., Aganna, E. & McDermott, M.F. (2004b) Response to anakinra in a de novo case of neonatal-onset multisystem inflammatory disease. Arthritis and Rheumatism, 50, 27082709.
  • Hinson, D.D., Ross, R.M., Krisans, S., Shaw, J.L., Kozich, V., Rolland, M.O., Divry, P., Mancini, J., Hoffmann, G.F. & Gibson, K.M. (1999) Identification of a mutation cluster in mevalonate kinase deficiency, including a new mutation in a patient of Mennonite ancestry. American Journal of Human Genetics, 65, 327335.
  • Hofer, M., Mahlaoui, N. & Prieur, A.M. (2006) A child with a systemic febrile illness - differential diagnosis and management. Best Practice & Research. Clinical Rheumatology, 20, 627640.
  • Hoffman, H.M. & Firestein, G.S. (2006) Anakinra for the treatment of neonatal-onset multisystem inflammatory disease. Nature Clinical Practice. Rheumatology, 2, 646647.
  • Hoffman, H.M., Wanderer, A.A. & Broide, D.H. (2001a) Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. Journal of Allergy and Clinical Immunology, 108, 615620.
  • Hoffman, H.M., Mueller, J.L., Broide, D.H., Wanderer, A.A. & Kolodner, R.D. (2001b) Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nature Genetics, 29, 301305.
  • Hoffman, H.M., Rosengren, S., Boyle, D.L., Cho, J.Y., Nayar, J., Mueller, J.L., Anderson, J.P., Wanderer, A.A. & Firestein, G.S. (2004) Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet, 364, 17791785.
  • Hoffmann, G.F., Charpentier, C., Mayatepek, E., Mancini, J., Leichsenring, M., Gibson, K.M., Divry, P., Hrebicek, M., Lehnert, W. & Sartor, K. (1993) Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics, 91, 915921.
  • Houten, S.M., Kuis, W., Duran, M., De Koning, T.J., Van Royen-Kerkhof, A., Romeijn, G.J., Frenkel, J., Dorland, L., De Barse, M.M., Huijbers, W.A., Rijkers, G.T., Waterham, H.R., Wanders, R.J. & Poll-The BT (1999a) Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nature Genetics, 22, 175177.
  • Houten, S.M., Romeijn, G.J., Koster, J., Gray, R.G., Darbyshire, P., Smit, G.P., De Klerk, J.B., Duran, M., Gibson, K.M., Wanders, R.J. & Waterham, H.R. (1999b) Identification and characterization of three novel missense mutations in mevalonate kinase cDNA causing mevalonic aciduria, a disorder of isoprene biosynthesis. Human Molecular Genetics, 8, 15231528.
  • Houten, S.M., Koster, J., Romeijn, G.J., Frenkel, J., Di, R.M., Caruso, U., Landrieu, P., Kelley, R.I., Kuis, W., Poll-The, B.T., Gibson, K.M., Wanders, R.J. & Waterham, H.R. (2001) Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome. European Journal of Human Genetics, 9, 253259.
  • Houten, S.M., Frenkel, J., Rijkers, G.T., Wanders, R.J., Kuis, W. & Waterham, H.R. (2002) Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. Human Molecular Genetics, 11, 31153124.
  • Houten, S.M., Schneiders, M.S., Wanders, R.J. & Waterham, H.R. (2003) Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients. Journal of Biological Chemistry, 278, 57365743.
  • Huggins, M.L., Radford, P.M., McIntosh, R.S., Bainbridge, S.E., Dickinson, P., Draper-Morgan, K.A., Tighe, P.J., Powell, R.J. & Todd, I. (2004) Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types. Arthritis and Rheumatism, 50, 26512659.
  • Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J.P., Belaiche, J., Almer, S., Tysk, C., O’Morain, C.A., Gassull, M., Binder, V., Finkel, Y., Cortot, A., Modigliani, R., Laurent-Puig, P., Gower-Rousseau, C., Macry, J., Colombel, J.F., Sahbatou, M. & Thomas, G. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature, 411, 599603.
  • Hull, K.M., Drewe, E., Aksentijevich, I., Singh, H.K., Wong, K., McDermott, E.M., Dean, J., Powell, R.J. & Kastner, D.L. (2002a) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore), 81, 349368.
  • Hull, K.M., Wong, K., Wood, G.M., Chu, W.S. & Kastner, D.L. (2002b) Monocytic fasciitis: a newly recognized clinical feature of tumor necrosis factor receptor dysfunction. Arthritis and Rheumatism, 46, 21892194.
  • Hull, K.M., Shoham, N., Chae, J.J., Aksentijevich, I. & Kastner, D.L. (2003) The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Current Opinion in Rheumatology, 15, 6169.
  • Hurst, M., Hull, K., Nicholls, D. & Ameratunga, R. (2005) Hereditary periodic fever syndrome sans fever or distinct periodicity presenting with psychosis. Journal of Clinical Rheumatology, 11, 329330.
  • Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K., Inamura, S., Kusumoto, S., Hashimoto, M., Foster, S.J., Moran, A.P., Fernandez-Luna, J.L. & Nunez, G. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease. Journal of Biological Chemistry, 278, 55095512.
  • Jacobelli, S., Andre, M., Alexandra, J.F., Dode, C. & Papo, T. (2007) Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS). Rheumatology (Oxford), 46, 12111212.
  • Jain, M.K. & Ridker, P.M. (2005) Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nature Reviews Drug Discovery, 4, 977987.
  • Jones, S.J., Ledgerwood, E.C., Prins, J.B., Galbraith, J., Johnson, D.R., Pober, J.S. & Bradley, J.R. (1999) TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1. Journal of Immunology, 162, 10421048.
  • Kallinich, T., Briese, S., Roesler, J., Rudolph, B., Sarioglu, N., Blankenstein, O., Keitzer, R., Querfeld, U. & Haffner, D. (2004) Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis. Journal of Rheumatology, 31, 25192522.
  • Kallinich, T., Hoffman, H.M., Roth, J. & Keitzer, R. (2005) The clinical course of a child with CINCA/NOMID syndrome improved during and after treatment with thalidomide. Scandinavian Journal of Rheumatology, 34, 246249.
  • Kanazawa, N., Okafuji, I., Kambe, N., Nishikomori, R., Nakata-Hizume, M., Nagai, S., Fuji, A., Yuasa, T., Manki, A., Sakurai, Y., Nakajima, M., Kobayashi, H., Fujiwara, I., Tsutsumi, H., Utani, A., Nishigori, C., Heike, T., Nakahata, T. & Miyachi, Y. (2005) Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood, 105, 11951197.
  • Kanneganti, T.D., Ozoren, N., Body-Malapel, M., Amer, A., Park, J.H., Franchi, L., Whitfield, J., Barchet, W., Colonna, M., Vandenabeele, P., Bertin, J., Coyle, A., Grant, E.P., Akira, S. & Nunez, G. (2006) Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature, 440, 233236.
  • Karachaliou, I., Karachalios, G., Charalabopoulos, A. & Charalabopoulos, K. (2005) Meningitis associated with familial Mediterranean fever. International Journal of Clinical Practice, 59(Suppl. 147), 6061.
  • Kastner, D.L. (2005) Hereditary periodic Fever syndromes. Hematology–American Society Hematology Educational Program Book, 2005, 7481.
  • Kelley, R.I. & Herman, G.E. (2001) Inborn errors of sterol biosynthesis. Annual Review of Genomics and Human Genetics, 2, 299341.
  • De Koning, H.J., Bodar, E.J., Van Der Meer, W.M. & Simon, A. (2007) Schnitzler syndrome: beyond the case reports. Review and follow-up of 94 patients with an emphasis on prognosis and treatment. Seminars in Arthritis and Rheumatism, 37, 137148.
  • Kurokawa, T., Kikuchi, T., Ohta, K., Imai, H. & Yoshimura, N. (2003) Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology, 110, 20402044.
  • Lachmann, H.J., Sengul, B., Yavuzsen, T.U., Booth, D.R., Booth, S.E., Bybee, A., Gallimore, J.R., Soyturk, M., Akar, S., Tunca, M. & Hawkins, P.N. (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford), 45, 746750.
  • Lamprecht, P., Moosig, F., Dam-Klages, S., Mrowietz, U., Csernok, E., Kirrstetter, M., Hmadi-Simab, K., Schroder, J.O. & Gross, W.L. (2004) Small vessel vasculitis and relapsing panniculitis in tumour necrosis factor receptor associated periodic syndrome (TRAPS). Annals of the Rheumatic Diseases, 63, 15181520.
  • Lequerre, T., Vittecoq, O., Saugier-Veber, P., Goldenberg, A., Patoz, P., Frebourg, T. & Le Loet, X. (2007) A cryopyrin-associated periodic syndrome with joint destruction. Rheumatology (Oxford), 46, 709714.
  • Leslie, K.S., Lachmann, H.J., Bruning, E., McGrath, J.A., Bybee, A., Gallimore, J.R., Roberts, P.F., Woo, P., Grattan, C.E. & Hawkins, P.N. (2006) Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations. Archives of Dermatology, 142, 15911597.
  • Li, J., Nishizawa, K., An, W., Hussey, R.E., Lialios, F.E., Salgia, R., Sunder-Plassmann, R. & Reinherz, E.L. (1998) A cdc15-like adaptor protein (CD2BP1) interacts with the CD2 cytoplasmic domain and regulates CD2-triggered adhesion. EMBO Journal, 17, 73207336.
  • Livneh, A., Langevitz, P., Zemer, D., Zaks, N., Kees, S., Lidar, T., Migdal, A., Padeh, S. & Pras, M. (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis and Rheumatism, 40, 18791885.
  • Lobito, A.A., Kimberley, F.C., Muppidi, J.R., Komarow, H., Jackson, A.J., Hull, K.M., Kastner, D.L., Screaton, G.R. & Siegel, R.M. (2006) Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood, 108, 13201327.
  • Long, S.S. (2005) Distinguishing among prolonged, recurrent, and periodic fever syndromes: approach of a pediatric infectious diseases subspecialist. Pediatric Clinics of North America, 52, 811835, vii.
  • Lovell, D.J., Bowyer, S.L. & Solinger, A.M. (2005) Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease. Arthritis and Rheumatism, 52, 12831286.
  • Majeed, H.A. (2000) Differential diagnosis of fever of unknown origin in children. Current Opinion in Rheumatology, 12, 439444.
  • Majeed, H.A., Al-Tarawna, M., El-Shanti, H., Kamel, B. & Al-Khalaileh, F. (2001) The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia. Report of a new family and a review. European Journal of Pediatrics, 160, 705710.
  • Mandey, S.H., Schneiders, M.S., Koster, J. & Waterham, H.R. (2006a) Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency. Human Mutation, 27, 796802.
  • Mandey, S.H., Kuijk, L.M., Frenkel, J. & Waterham, H.R. (2006b) A role for geranylgeranylation in interleukin-1beta secretion. Arthritis and Rheumatism, 54, 36903695.
  • Marchetti, F., Barbi, E., Tommasini, A., Oretti, C. & Ventura, A. (2004) Inefficacy of etanercept in a child with hyper-IgD syndrome and periodic fever. Clinical and Experimental Rheumatology, 22, 791792.
  • Mariathasan, S., Weiss, D.S., Newton, K., McBride, J., O’Rourke, K., Roose-Girma, M., Lee, W.P., Weinrauch, Y., Monack, D.M. & Dixit, V.M. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature, 440, 228232.
  • Martinon, F. & Tschopp, J. (2004) Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell, 117, 561574.
  • Martinon, F. & Tschopp, J. (2007) Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death and Differentiation, 14, 1022.
  • Martinon, F., Burns, K. & Tschopp, J. (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Molecular Cell, 10, 417426.
  • Masters, S.L., Lobito, A.A., Chae, J. & Kastner, D.L. (2006) Recent advances in the molecular pathogenesis of hereditary recurrent fevers. Current Opinion in Allergy and Clinical Immunology, 6, 428433.
  • Masumoto, J., Dowds, T.A., Schaner, P., Chen, F.F., Ogura, Y., Li, M., Zhu, L., Katsuyama, T., Sagara, J., Taniguchi, S., Gumucio, D.L., Nunez, G. & Inohara, N. (2003) ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. Biochemical and Biophysical Research Communications, 303, 6973.
  • Matsubara, T., Hasegawa, M., Shiraishi, M., Hoffman, H.M., Ichiyama, T., Tanaka, T., Ueda, H., Ishihara, T. & Furukawa, S. (2006) A severe case of chronic infantile neurologic, cutaneous, articular syndrome treated with biologic agents. Arthritis and Rheumatism, 54, 23142320.
  • Matsubayashi, T., Sugiura, H., Arai, T., Oh-Ishi, T. & Inamo, Y. (2006) Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIAS1 gene. Acta Paediatrica, 95, 246249.
  • McDermott, M.F., Aksentijevich, I., Galon, J., McDermott, E.M., Ogunkolade, B.W., Centola, M., Mansfield, E., Gadina, M., Karenko, L., Pettersson, T., McCarthy, J., Frucht, D.M., Aringer, M., Torosyan, Y., Teppo, A.M., Wilson, M., Karaarslan, H.M., Wan, Y., Todd, I., Wood, G., Schlimgen, R., Kumarajeewa, T.R., Cooper, S.M., Vella, J.P., Amos, C.I., Mulley, J., Quane, K.A., Molloy, M.G., Ranki, A., Powell, R.J., Hitman, G.A., O’Shea, J.J. & Kastner, D.L. (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell, 97, 133144.
  • Metyas, S.K. & Hoffman, H.M. (2006) Anakinra prevents symptoms of familial cold autoinflammatory syndrome and Raynaud’s disease. Journal of Rheumatology, 33, 20852087.
  • Metyas, S., Arkfeld, D.G., Forrester, D.M. & Ehresmann, G.R. (2004) Infliximab treatment of familial Mediterranean Fever and its effect on secondary AA amyloidosis. Journal of Clinical Rheumatology, 10, 134137.
  • Milman, N., Andersen, C.B., Hansen, A., Van Overeem, H.T., Nielsen, F.C., Fledelius, H., Ahrens, P. & Nielsen, O.H. (2006) Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation. APMIS, 114, 912919.
  • Minden, K., Aganna, E., McDermott, M.F. & Zink, A. (2004) Tumour necrosis factor receptor associated periodic syndrome (TRAPS) with central nervous system involvement. Annals of the Rheumatic Diseases, 63, 13561357.
  • Mirault, T., Launay, D., Cuisset, L., Hachulla, E., Lambert, M., Queyrel, V., Quemeneur, T., Morell-Dubois, S. & Hatron, P.Y. (2006) Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. Arthritis and Rheumatism, 54, 16971700.
  • Montero, M.T., Hernandez, O., Suarez, Y., Matilla, J., Ferruelo, A.J., Martinez-Botas, J., Gomez-Coronado, D. & Lasuncion, M.A. (2000) Hydroxymethylglutaryl-coenzyme A reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells. Atherosclerosis, 153, 303313.
  • Montero, M.T., Matilla, J., Gomez-Mampaso, E. & Lasuncion, M.A. (2004) Geranylgeraniol regulates negatively caspase-1 autoprocessing: implication in the Th1 response against Mycobacterium tuberculosis. Journal of Immunology, 173, 49364944.
  • Mor, A., Pillinger, M.H., Kishimoto, M., Abeles, A.M. & Livneh, A. (2007) Familial Mediterranean fever successfully treated with etanercept. Journal of Clinical Rheumatology, 13, 3840.
  • Muckle, T.J. (1979) The ‘Muckle-Wells’ syndrome. British Journal of Dermatology, 100, 8792.
  • Nagashima, T., Okazaki, H., Yudoh, K., Matsuno, H. & Minota, S. (2006) Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis. Arthritis and Rheumatism, 54, 579586.
  • Nevyjel, M., Pontillo, A., Calligaris, L., Tommasini, A., D’Osualdo, A., Waterham, H.R., Granzotto, M., Crovella, S., Barbi, E. & Ventura, A. (2007) Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency. Pediatrics, 119, e523e527.
  • Nigrovic, P.A. & Sundel, R.P. (2001) Treatment of TRAPS with etanercept: use in pediatrics. Clinical and Experimental Rheumatology, 19, 484485.
  • Nowlan, M.L., Drewe, E., Bulsara, H., Esposito, N., Robins, R.A., Tighe, P.J., Powell, R.J. & Todd, I. (2006) Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A. Rheumatology (Oxford), 45, 3137.
  • O’Connell, S.M., O’Regan, G.M., Bolger, T., Hoffman, H.M., Cant, A., Irvine, A.D. & Watson, R.M. (2007) Response to IL-1-receptor antagonist in a child with familial cold autoinflammatory syndrome. Pediatric Dermatology, 24, 8589.
  • O’Connor, Jr, W., Harton, J.A., Zhu, X., Linhoff, M.W. & Ting, J.P. (2003) Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-kappa B suppressive properties. Journal of Immunology, 171, 63296333.
  • Ogura, Y., Inohara, N., Benito, A., Chen, F.F., Yamaoka, S. & Nunez, G. (2001) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. Journal of Biological Chemistry, 276, 48124818.
  • Ozgocmen, S., Ozcakar, L., Ardicoglu, O., Kocakoc, E., Kaya, A. & Kiris, A. (2006) Familial Mediterranean fever responds well to infliximab: single case experience. Clinical Rheumatology, 25, 8387.
  • Ozkaya, O., Bek, K., Alaca, N., Ceyhan, M., Acikgoz, Y. & Tasdemir, H.A. (2007) Cerebral vasculitis in a child with Henoch-Schonlein purpura and familial Mediterranean fever. Clinical Rheumatology, 26, 17291732.
  • Papin, S., Cuenin, S., Agostini, L., Martinon, F., Werner, S., Beer, H.D., Grutter, C., Grutter, M. & Tschopp, J. (2007) The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death and Differentiation, 14, 14571466.
  • Pinto, A., Lindemeyer, R.G. & Sollecito, T.P. (2006) The PFAPA syndrome in oral medicine: differential diagnosis and treatment. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 102, 3539.
  • Prieur, A.M. (2001) A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy. Clinical and Experimental Rheumatology, 19, 103106.
  • Ramos, E., Arostegui, J.I., Campuzano, S., Rius, J., Bousono, C. & Yague, J. (2005) Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS). Rheumatology (Oxford), 44, 10721073.
  • Revaz, S., Dudler, J. & Kai-Lik, S.A. (2006) Fever and musculoskeletal symptoms in an adult: differential diagnosis and management. Best Practice & Research Clinical Rheumatology, 20, 641651.
  • Richards, N., Schaner, P., Diaz, A., Stuckey, J., Shelden, E., Wadhwa, A. & Gumucio, D.L. (2001) Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. Journal of Biological Chemistry, 276, 3932039329.
  • Rigante, D., Ansuini, V., Bertoni, B., Pugliese, A.L., Avallone, L., Federico, G. & Stabile, A. (2006a) Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome. Rheumatology International, 27, 97100.
  • Rigante, D., Ansuini, V., Caldarelli, M., Bertoni, B., La Torraca, I. & Stabile, A. (2006b) Hydrocephalus in CINCA syndrome treated with anakinra. Childs Nervous System, 22, 334337.
  • Rosengren, S., Mueller, J.L., Anderson, J.P., Niehaus, B.L., Misaghi, A., Anderson, S., Boyle, D.L. & Hoffman, H.M. (2007) Monocytes from familial cold autoinflammatory syndrome patients are activated by mild hypothermia. Journal of Allergy and Clinical Immunology, 119, 991996.
  • Rosenstiel, P., Fantini, M., Brautigam, K., Kuhbacher, T., Waetzig, G.H., Seegert, D. & Schreiber, S. (2003) TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology, 124, 10011009.
  • Rynne, M., Maclean, C., Bybee, A., McDermott, M.F. & Emery, P. (2006) Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonism. Annals of the Rheumatic Diseases, 65, 533534.
  • Sakallioglu, O., Duzova, A. & Ozen, S. (2006) Etanercept in the treatment of arthritis in a patient with familial Mediterranean fever. Clinical and Experimental Rheumatology, 24, 435437.
  • Sarkar, A., Duncan, M., Hart, J., Hertlein, E., Guttridge, D.C. & Wewers, M.D. (2006) ASC directs NF-kappaB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions. Journal of Immunology, 176, 49794986.
  • Schaffer, J.V., Chandra, P., Keegan, B.R., Heller, P. & Shin, H.T. (2007) Widespread granulomatous dermatitis of infancy: an early sign of Blau syndrome. Archives of Dermatology, 143, 386391.
  • Schneiders, M.S., Houten, S.M., Turkenburg, M., Wanders, R.J. & Waterham, H.R. (2006) Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency. Arthritis and Rheumatism, 54, 23062313.
  • Seitz, M., Kamgang, R.K., Simon, H.U. & Villiger, P.M. (2005) Therapeutic interleukin (IL) 1 blockade normalises increased IL1 beta and decreased tumour necrosis factor alpha and IL10 production in blood mononuclear cells of a patient with CINCA syndrome. Annals of the Rheumatic Diseases, 64, 18021803.
  • Serratrice, J., De Roux-Serratrice, C., Disdier, P., Dode, C. & Weiller, P.J. (2007) Dramatic etanercept-induced remission of relapsing febrile sciatic neuralgia related to p46l mutation of the tnfrsf1a gene. Clinical Rheumatology, 26, 15351536.
  • Shoham, N.G., Centola, M., Mansfield, E., Hull, K.M., Wood, G., Wise, C.A. & Kastner, D.L. (2003) Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proceedings of the National Academy of Sciences of the United States of America, 100, 1350113506.
  • Shohat, M., Danon, Y.L. & Rotter, J.I. (1992) Familial Mediterranean fever: analysis of inheritance and current linkage data. American Journal of Medical Genetics, 44, 183188.
  • Siebert, S., Amos, N., Fielding, C.A., Wang, E.C., Aksentijevich, I., Williams, B.D. & Brennan, P. (2005a) Reduced tumor necrosis factor signaling in primary human fibroblasts containing a tumor necrosis factor receptor superfamily 1A mutant. Arthritis and Rheumatism, 52, 12871292.
  • Siebert, S., Fielding, C.A., Williams, B.D. & Brennan, P. (2005b) Mutation of the extracellular domain of tumour necrosis factor receptor 1 causes reduced NF-kappaB activation due to decreased surface expression. FEBS Letters, 579, 51935198.
  • Simon, A. (2007) Approach to the diagnosis of hereditary autoinflammatory syndromes. Future Rheumatology, 2, 58.
  • Simon, A. & Van Der Meer, J.W. (2007) Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 292, R86R98.
  • Simon, A., Cuisset, L., Vincent, M.F., Van Der Velde-Visser, S.D., Delpech, M., Van Der Meer, J.W. & Drenth, J.P. (2001a) Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-igd and periodic fever syndrome: its application as a diagnostic tool. Annals of Internal Medicine, 135, 338343.
  • Simon, A., Van, D.M., Tighe, P.J., Van Der Meer, J.W. & Drenth, J.P. (2001b) Genetic analysis as a valuable key to diagnosis and treatment of periodic Fever. Archives of Internal Medicine, 161, 24912493.
  • Simon, A., Mariman, E.C., Van Der Meer, J.W. & Drenth, J.P. (2003) A founder effect in the hyperimmunoglobulinemia D and periodic fever syndrome. American Journal of Medicine, 114, 148152.
  • Simon, A., Bodar, E.J., Van Der Hilst, J.C., Van Der Meer, J.W., Fiselier, T.J., Cuppen, M.P. & Drenth, J.P. (2004a) Beneficial response to interleukin 1 receptor antagonist in traps. American Journal of Medicine, 117, 208210.
  • Simon, A., Drewe, E., Van Der Meer, J.W., Powell, R.J., Kelley, R.I., Stalenhoef, A.F. & Drenth, J.P. (2004b) Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clinical Pharmacology and Therapeutics, 75, 476483.
  • Simon, A., Van Der Meer, J.W., Vesely, R., Myrdal, U., Yoshimura, K., Duys, P. & Drenth, J.P. (2006) Approach to genetic analysis in the diagnosis of hereditary autoinflammatory syndromes. Rheumatology (Oxford), 45, 269273.
  • Soylu, A., Kasap, B., Turkmen, M., Saylam, G.S. & Kavukcu, S. (2006) Febrile myalgia syndrome in familial Mediterranean fever. Journal of Clinical Rheumatology, 12, 9396.
  • Stehlik, C., Fiorentino, L., Dorfleutner, A., Bruey, J.M., Ariza, E.M., Sagara, J. & Reed, J.C. (2002) The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways. Journal of Experimental Medicine, 196, 16051615.
  • Stichweh, D.S., Punaro, M. & Pascual, V. (2005) Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatric Dermatology, 22, 262265.
  • Storey, H., Stewart, A., Vandenabeele, P. & Luzio, J.P. (2002) The p55 tumour necrosis factor receptor TNFR1 contains a trans-Golgi network localization signal in the C-terminal region of its cytoplasmic tail. Biochemical Journal, 366, 1522.
  • Sutterwala, F.S., Ogura, Y., Szczepanik, M., Lara-Tejero, M., Lichtenberger, G.S., Grant, E.P., Bertin, J., Coyle, A.J., Galan, J.E., Askenase, P.W. & Flavell, R.A. (2006) Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity, 24, 317327.
  • Takada, K., Aksentijevich, I., Mahadevan, V., Dean, J.A., Kelley, R.I. & Kastner, D.L. (2003) Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis and Rheumatism, 48, 26452651.
  • Takeda, K., Kaisho, T. & Akira, S. (2003) Toll-like receptors. Annual Review of Immunology, 21, 335376.
  • Tallon, B. & Corkill, M. (2006) Peculiarities of PAPA syndrome. Rheumatology (Oxford), 45, 11401143.
  • Tchernitchko, D., Moutereau, S., Legendre, M., Delahaye, A., Cazeneuve, C., Lacombe, C., Grateau, G. & Amselem, S. (2005) MEFV analysis is of particularly weak diagnostic value for recurrent fevers in Western European Caucasian patients. Arthritis and Rheumatism, 52, 36033605.
  • Teoh, S.C., Sharma, S., Hogan, A., Lee, R., Ramanan, A.V. & Dick, A.D. (2007) Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome. British Journal of Ophthalmology, 91, 263264.
  • The French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. The French FMF Consortium. Nature Genetics, 17, 2531.
  • The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell, 90, 797807.
  • Thornton, B.D., Hoffman, H.M., Bhat, A. & Don, B.R. (2007) Successful treatment of renal amyloidosis due to familial cold autoinflammatory syndrome using an interleukin 1 receptor antagonist. American Journal of Kidney Diseases, 49, 477481.
  • Ting, T.V., Scalzi, L.V. & Hashkes, P.J. (2007) Nonclassic neurologic features in cryopyrin-associated periodic syndromes. Pediatric Neurology, 36, 338341.
  • Todd, I., Radford, P.M., Draper-Morgan, K.A., McIntosh, R., Bainbridge, S., Dickinson, P., Jamhawi, L., Sansaridis, M., Huggins, M.L., Tighe, P.J. & Powell, R.J. (2004) Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour. Immunology, 113, 6579.
  • Topaloglu, R., Ozaltin, F., Yilmaz, E., Ozen, S., Balci, B., Besbas, N. & Bakkaloglu, A. (2005) E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever. Annals of the Rheumatic Diseases, 64, 750752.
  • Touitou, I. (2007) INFEVERS: an online database for autoinflammatory mutations. Available at: http://fmf.igh.cnrs.fr/ISSAID/infevers/ (accessed 1 May 2007).
  • Touitou, I., Lesage, S., McDermott, M., Cuisset, L., Hoffman, H., Dode, C., Shoham, N., Aganna, E., Hugot, J.P., Wise, C., Waterham, H., Pugnere, D., Demaille, J. & Sarrauste de, M.C. (2004) Infevers: an evolving mutation database for auto-inflammatory syndromes. Human Mutation, 24, 194198.
  • Touitou, I., Sarkisian, T., Medlej-Hashim, M., Tunca, M., Livneh, A., Cattan, D., Yalcinkaya, F., Ozen, S., Majeed, H., Ozdogan, H., Kastner, D., Booth, D., Ben-Chetrit, E., Pugnere, D., Michelon, C., Seguret, F. & Gershoni-Baruch, R. (2007) Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis and Rheumatism, 56, 17061712.
  • Tunca, M., Tankurt, E., Akbaylar, A.H., Akar, S., Hizli, N. & Gonen, O. (1997) The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: a pilot study. British Journal of Rheumatology, 36, 10051008.
  • Tunca, M., Akar, S., Soyturk, M., Kirkali, G., Resmi, H., Akhunlar, H., Gonen, O., Gallimore, J.R., Hawkins, P.N. & Tankurt, E. (2004) The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: a double-blind, placebo-controlled trial. Clinical and Experimental Rheumatology, 22, S37S40.
  • Tunca, M., Akar, S., Onen, F., Ozdogan, H., Kasapcopur, O., Yalcinkaya, F., Tutar, E., Ozen, S., Topaloglu, R., Yilmaz, E., Arici, M., Bakkaloglu, A., Besbas, N., Akpolat, T., Dinc, A. & Erken, E. (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore), 84, 111.
  • Vanderschueren, S., Knockaert, D., Adriaenssens, T., Demey, W., Durnez, A., Blockmans, D. & Bobbaers, H. (2003) From prolonged febrile illness to fever of unknown origin: the challenge continues. Archives of Internal Medicine, 163, 10331041.
  • Wajant, H., Pfizenmaier, K. & Scheurich, P. (2003) Tumor necrosis factor signaling. Cell Death and Differentiation, 10, 4565.
  • Watts, R.A., Nicholls, A. & Scott, D.G. (1994) The arthropathy of the Muckle-Wells syndrome. British Journal of Rheumatology, 33, 11841187.
  • Weyhreter, H., Schwartz, M., Kristensen, T.D., Valerius, N.H. & Paerregaard, A. (2003) A new mutation causing autosomal dominant periodic fever syndrome in a Danish family. Journal of Pediatrics, 142, 191193.
  • Wise, C.A., Gillum, J.D., Seidman, C.E., Lindor, N.M., Veile, R., Bashiardes, S. & Lovett, M. (2002) Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Human Molecular Genetics, 11, 961969.
  • Yang, H. & Reinherz, E.L. (2006) CD2BP1 modulates CD2-dependent T cell activation via linkage to protein tyrosine phosphatase (PTP)-PEST. Journal of Immunology, 176, 58985907.
  • Yu, J.W., Wu, J., Zhang, Z., Datta, P., Ibrahimi, I., Taniguchi, S., Sagara, J., Fernandes-Alnemri, T. & Alnemri, E.S. (2006) Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death and Differentiation, 13, 236249.
  • Yuksel, S., Yalcinkaya, F., Acar, B., Ozcakar, Z.B., Ozturk, B. & Ekim, M. (2006) Clinical improvement with infliximab in a child with amyloidosis secondary to familial Mediterranean fever. Rheumatology (Oxford), 45, 13071308.